Introduction 42
Regulating messenger RNA (mRNA) abundance is of central importance during both 43 cellular homeostasis and disease. While it is intuitive that transcriptional changes in the nucleus 44 impact RNA levels in the cytoplasm, evidence in both yeast and mammalian cells now indicates 45 that the converse is also true: altered cytoplasmic mRNA decay rates can broadly impact 46 transcription by RNA polymerase II (Pol II). In yeast, stabilizing the cytoplasmic mRNA pool by 47 removing mRNA decay factors such as Xrn1 causes a compensatory decrease in Pol II 48 transcription (1-5). Furthermore, reducing or slowing Pol II transcription leads to an increase in 49 During MHV68 infection, in addition to host mRNA, cytoplasmic viral mRNA is 73 susceptible to cleavage by muSOX (23). However, measurements of nascent transcript 74 production from a subset of viral promoters suggested that viral genes are robustly transcribed 75 during the stage of infection when host transcription is reduced (24) . An outstanding question is 76 how these viral promoters escape mRNA decay-induced transcriptional repression despite being 77 transcribed by RNA Pol II. Here, we measured Pol II occupancy across the mouse and MHV68 78 genomes in infected cells to more comprehensively define how accelerated mRNA decay 79 impacts polymerase occupancy. Our data demonstrate a genome-wide reduction in Pol II 80 recruitment at host promoters under conditions of increased mRNA decay. In contrast, Pol II 81 occupancy of the viral genome appears broadly resistant to the effects of mRNA degradation. 82
This protection is not conferred by viral promoter sequences; instead, location on the replicating 83 viral genome is both necessary and sufficient to escape the transcriptional effects of mRNA 84 decay. We propose a model in which DNA amplified in viral replication compartments, unlike 85 the cellular chromatin, is immune to transcriptional repression during accelerated cytoplasmic 86 mRNA decay. Thus, while both viral and cellular mRNA pools are susceptible to cytoplasmic 87 degradation, transcriptional repopulation selectively counteracts this loss for viral genes. 88 89 Results 90 Accelerated RNA decay broadly reduces Pol II occupancy 91 We previously reported that Pol II occupancy at several individual mammalian promoters 92 was significantly reduced during accelerated cytoplasmic mRNA decay (22, 24) . To more 93 comprehensively assess the extent of mRNA decay-induced transcriptional repression, we 94 evaluated global Pol II occupancy by chromatin immunoprecipitation and deep sequencing 95 (ChIP-seq) in mock versus MHV68 infected MC57G mouse fibroblasts at 24 hours post 96 infection (hpi). As a control, we also infected cells with a version of MHV68 containing the 97 point mutation R443I in the viral muSOX endonuclease gene, which reduces its mRNA cleavage 98 activity. R443I retains a similar lytic cycle and infectious capability to wildtype (WT) MHV68 in 99 vivo and in vitro its infectious capability is similar to MHV68 in mouse fibroblasts (6, 23) . 100 MHV68-infected cells displayed promoter-proximal loss of Pol II at 86% of loci compared to 101 mock-infected cells, averaged across two biological replicates and subtracting input signal (Fig 102 1A and S1 Fig A) . Loss of Pol II occupancy was primarily due to muSOX-induced mRNA 103 decay, as this signal loss either did not occur or was reduced at 67% of these loci during 104 infection with R443I MHV68 (Fig 1A and S1 Fig A) . Sixty-three genes, or 1.3% of loci, showed 105
higher Pol II occupancy in WT infection as compared to mock infection, although these did not 106 share any common GO terms (S1 Table) . A representative genome browser view shows reduced 107
Pol II signal throughout Srsf2 in the MHV68 condition of two replicate ChIP experiments. We 108 independently validated the ChIP-seq results by ChIP-qPCR at the Rplp0 and Fus promoters, 109 both of which showed a significant reduction of Pol II occupancy in cells infected with WT but 110 not R443I MHV68 ( Fig 1C) , as did a validation using a second antibody that recognizes the N-111 terminus of the major subunit of Pol II, Rpb1 (Fig1D). The genome-wide reduction in poised Pol 112 II in WT but not R443I infected cells was also evident when the sequencing reads from positions 113 -2000 to +4000 around the transcription start sites (TSS) were plotted as a histogram ( Fig 1G and  114   S1 Fig B) . The variability between replicates in R443I recovery ( Fig 1B) is likely due to 115 differences in the extent of host shutoff reduction between replicates due to R443I reducing 116 muSOX activity while not being a catalytic mutant. 117
To assess the stage of transcription impacted by RNA decay, we compared the amount of 118 Pol II in promoter regions (-50 to +200) and the amount of Pol II in gene bodies (+200 to +5000) 119 between mock and infected samples. Consistent with the above analyses, MHV68 infected cells 120 contained markedly less promoter proximal Pol II than uninfected cells, and this signal was 121 partially recovered in the R443I infection ( Fig 1E) . Genes with impaired Pol II promoter binding 122 during MHV68 infection also had less Pol II within the gene body compared to mock infected 123 cells, which again was not observed during R443I infection ( Fig 1F) . Notably, the difference in 124 regression line slopes between MHV68 and mock infected cells was clearly more marked when 125 comparing Pol II promoter occupancy, suggesting that the primary transcriptional defect is at the 126 stage of initiation. This is consistent with data from previous studies that found no defect in 127 serine 2 phosphorylation of elongating Pol II and no consistent change to Pol II elongation 128 during MHV68 infection (22, 24) . 129
Finally, to assess if RNA decay affected transcription termination, we plotted sequencing 130 reads between 1kb upstream and 1kb downstream of the transcription termination site (TTS) as a 131 histogram ( Fig 1H and S1 Fig D) . TTS-proximal Pol II shows no defect in termination in either 132 infection condition, suggesting Pol II removal from host transcripts is not impacted by MHV68 133 infection or by RNA decay. 134 135 Pol II recruitment to viral genes is not affected by RNA decay 136 Herpesviral genes are transcribed in the nucleus by mammalian Pol II, and thus could be 137 similarly subjected to the mRNA decay-induced transcriptional repression observed across the 138 host genome. We therefore analyzed Pol II occupancy of the viral genome in WT MHV68 and 139 R443I infected cells to determine how viral genes respond to RNA decay. The average Pol II 140 signature across 82 viral ORFs between -500 and +500 around the TSS was comparable in cells 141 infected with WT or R443I MHV68, with a slightly higher signal in the R443I infection ( Fig  142   2A ). Indeed, there was a robust and widespread Pol II signal in both infection conditions across 143 the viral genome ( Fig 2B) . Thus, herpesviral genes appear to escape mRNA decay-induced 144 transcriptional repression. 145
In contrast to host genes, we did not observe peaks of promoter-proximal Pol II on the 146 viral genome in our ChIP-seq data (Fig 2A and B) . Pol II ChIP qPCR across various regions of 147 ORF54 and ORF37 also showed a similar Pol II signal throughout each gene body and at their 148 promoter. We did note a decrease in signal near the TTS of ORF54, however this was true for 149 both WT and R443I infections ( Fig 2C) . We hypothesize that pervasive transcription of the viral 150 genome at 24 hpi, compounded by the presence of TSSs on both Watson and Crick strands, 151 likely contributes to this phenotype. 152
153

PABPC is not excluded from viral replication compartments 154
We next considered how the viral genome maintains high levels of Pol II occupancy 155 during accelerated mRNA decay. During replication, viral DNA is transcribed within viral 156 replication compartments (RCs) in the nucleus, which exclude host DNA and thus stain poorly 157 with DAPI (25-27). Although they are not membrane bound, these compartments selectively 158 enrich for factors required for viral replication (such as the viral processivity factor ORF59) and 159 gene expression (such as Pol II) (28-30). Virus-induced mRNA decay causes increased 160 trafficking of cytoplasmic poly(A) binding protein (PABPC) from the cytoplasm to the nucleus, 161 which we have recently linked to transcriptional repression (22,31). To determine whether 162 replication compartments selectively exclude nuclear PABPC as a means of avoiding 163 transcriptional repression, we monitored its localization in cells lytically infected with MHV68 164 or KSHV. As expected, the majority of infected cells displayed increased nuclear PABPC 165 compared to unreactivated or uninfected cells as measured by immunofluorescence (IF). We 166 further saw that PABPC was not excluded from replication compartments ( Fig 3A, B and S2 Fig  167   A ). To determine PABPC localization relative to RCs, we first identified cells with RCs by 168 looking for regions of Pol II or ORF59 staining that excluded DAPI. We then quantified nuclear 169 PABPC pixel intensity, and counted cells as having an overlapping RC/PABPC signal when the 170 PABPC pixel intensity was at least 2x that of cells without nuclear PABPC from the same image. 171
Indeed, 85 percent of MHV68 infected cells showed overlapping PABPC/Pol II signal and 90 172 percent of reactivated iSLKs showed an overlapping PABPC/ORF59 signal ( Fig 3C) . Thus, 173 PABPC exclusion from RCs is unlikely to underlie viral promoter escape. 174 175
Viral promoters fail to escape transcriptional repression outside of the viral genome 176
We then tested whether viral promoter sequence elements were sufficient to enable 177 escape by querying whether they conferred resistance to transcriptional repression upon 178 relocation from the viral genome into the host DNA. We inserted the MHV68 late promoter M7 179 or the KSHV LANA promoter upstream of a puromycin resistance cassette into 293T cell 180 chromatin using either lentiviral transduction or random plasmid DNA integration, respectively. 181
We induced mRNA decay and host transcriptional repression in these cells by expression of 182 MHV68 muSOX or the herpes simplex virus type 1 (HSV-1) endonuclease vhs. Similar to the 183 host promoters Gapdh and Rplp0, Pol II recruitment to both integrated viral promoters was 184 repressed upon infection with MHV68 but not with R443I ( Fig 4A and 5B) . 185
To confirm that viral promoters integrated into the host genome were also repressed in 186 the context of infection, we infected MC57G cells containing an integrated MHV68 M4 187 promoter-driven puromycin cassette with MHV68. Indeed, the M4 promoter was repressed to a 188 similar degree as host Fus and Rplp0 promoters during infection with WT MHV68 but not the 189 mRNA decay-deficient MHV68 R443I ( Fig 4C) . In summary, these data argue against the 190 presence of protective elements within viral promoters, and instead suggest that the chromatin 191 context or location on the viral genome underlies escape from mRNA decay-induced 192 transcriptional repression. 193 194
Non-MHV68 promoters escape repression on the viral genome 195
A prediction from the above results is that non-MHV68 promoters would gain protection 196 from transcriptional repression when present on the replicating viral genome. To test this, we 197 measured the Pol II occupancy and transcriptional potential of the cytomegalovirus (CMV) 198 promoter, which drives green fluorescent protein (GFP) expression on the MHV68 genome. 199
Unlike alpha-and gammaherpesviruses, the betaherpesvirus CMV does not accelerate mRNA 200 decay. Furthermore, in either a plasmid context or when integrated into 293T cells, the CMV 201 promoter is strongly repressed during muSOX-induced mRNA decay. This is seen by 4SU 202 incorporation measuring nascent RNA production -similar to the control ActB gene -and by Pol 203 II recruitment, similar to the control Fus and Rplp0 promoters ( Fig 5A and B) . However, in the 204 context of the replicating MHV68 genome, the CMV-GFP promoter had a Pol II ChIP-seq signal 205 during both MHV68 WT and R443I infection that was not markedly different from several other 206 viral genes (ORFs 4, 25, 48, 52, 72, M11) ( Fig 5C) . 207
Finally, we evaluated whether the lytic stage of infection was necessary to confer escape 208 from transcriptional repression, or whether some other feature of the non-replicating viral 209 genome was important. To this end, we examined Pol II occupancy at promoters of several genes 210 expressed from the KSHV genome during latent infection in 293T cells, when the viral DNA is 211 maintained as an episome but not amplified in replication compartments. Latent infection does 212 not promote mRNA turnover, and thus we transfected muSOX into these cells to stimulate 213 mRNA turnover in the absence of lytic replication. Similar to the host genes Gapdh and Rplp0, 214
we observed an RNA decay-induced repression of Pol II occupancy at the latent viral promoter 215 LANA while the viral K1 promoter was repressed in 4 out of 5 experiments ( Fig 5D) . We also 216 observed repression of the human Ef1a promoter, which is present on the KSHV viral episome 217 as a driver of the GFP reporter gene ( Fig 5D) . In sum, these observations indicate that the viral 218 Across the host genome, Pol II appears to be most strongly affected at the stage of 232 recruitment. The reduction in promoter-proximal Pol II is propagated into the gene body, 233 although the differences there were less pronounced, suggesting that once transcription of a gene 234 initiates there are not subsequent blocks to elongation. This agrees with prior studies of 235 individual host loci in MHV68 infected or muSOX expressing cells (22,24). The population of 236
Pol II that is promoter-proximal and measured during a ChIP experiment has been shown to 237 comprise a combination of actively engaged Pol II as well as Pol II transiently binding to the 238 DNA. Thus, a large reduction in promoter-proximal Pol II may not be expected to be borne out 239 in the gene body (32). Additionally, the antibody we use in this study binds with higher affinity 240 to hypophosphorylated Pol II(33), likely affecting our ability to pull down elongating and 241 phosphorylated forms of Pol II. We also did not observe a defect in transcription termination, or 242 evidence of polymerases on the DNA after TTSs, suggesting that the gammaherpesvirus MHV68 243 does not induce the termination defect and run-on transcription of host genes recently described 244 in HSV-1 (34). 245
Two pieces of evidence indicate that reduction of Pol II at host genes is unlikely due to 246 sequestration of or competition for the transcription machinery by the viral DNA. First, infection 247 with the mRNA decay mutant virus R443I, which replicates its viral genome to WT levels (6), 248 does not induce the widespread reduction in Pol II recruitment to host promoters. Second, 249 transfection of muSOX alone (or other broad acting viral endonucleases) in the absence of viral 250 infection is sufficient to induce transcriptional repression at host promoters. Therefore, we 251 instead favor the hypothesis that one or more cellular proteins released from degrading mRNA 252 fragments triggers a signaling event that restricts transcription machinery occupancy of 253 mammalian chromatin (22). 254
Reduced Pol II occupancy of the host genome during MHV68 infection parallels 255 infection data from the alphaherpesvirus HSV-1. HSV-1 infection results in a genome-wide 256 reduction in Pol II occupancy of host chromatin and reduced nascent RNA production of the 257 majority of host transcripts (34-36). Furthermore, early data showed that while the endogenous 258 mouse b-globin locus was transcriptionally repressed during HSV-1 infection, its expression was 259 rescued upon integration of the b-globin gene into the HSV-1 genome (37,38). Experiments with 260 gene-specific null viruses have implicated immediate early (IE) proteins in the HSV-1 261 transcriptional repression phenotype, including ICP27, which can accelerate mRNA turnover 262 (36,39). Additionally, we have previously published, and confirm in this report, that transfection 263 of HSV-1 vhs, another broad acting endoribonuclease, is sufficient to induce reduced Pol II 264 occupancy of several host promoters (21). Thus, in addition to targeting host and viral mRNAs 265 for cytoplasmic decay, both alpha and gammaherpesviruses restrict Pol II occupancy of the host 266 genome, although additional work is needed to establish whether the underlying mechanism is 267 similar. 268
During the lytic stage of herpesvirus infection, viral DNA is localized to replication 269 compartments. These non-membrane bound structures are sites of viral genome replication, 270 transcription, and packaging (40). They are enriched for many host and viral proteins involved in 271 these processes, including chromatin modifying factors and Pol II (28-30). Replication 272 compartments grow and coalesce over infection, excluding host chromatin, which becomes 273 pushed to the nuclear periphery (25-27). We recently showed that muSOX and Xrn1-coordinated 274 mRNA decay causes differential trafficking of many cellular RNA binding proteins between the 275 cytoplasm and nucleus. Knockdown and overexpression studies suggested that at least one of 276 these proteins, PABPC, is associated with transcriptional repression (22). Here, we detected 277 PABPC in viral replication compartments of infected cell nuclei, indicating that selective 278 exclusion of PABPC from these compartments is not the mechanism by which the viral genome In conclusion, decay-coupled transcriptional repression is a novel facet of viral 299 manipulation of the cellular gene expression landscape. We hypothesize that the ability to escape 300 from transcriptional repression is linked to the open conformation of viral DNA in replication 301 compartments, and that this helps these viruses counteract decay-induced viral transcript loss. 302
While widespread mRNA decay has been shown to facilitate immune evasion, gene expression 303 control, and latency establishment, the robust viral transcription we document here presents a 304 parsimonious explanation for a novel way in which the virus benefits from accelerated decay. 305 306 307 
Materials and Methods
MC57G mouse fibroblast cells (ATCC), 293T cells (ATCC) and NIH 3T3 cells (ATCC) 322
were maintained in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS). 323 iSLK BAC16 cells (48) were maintained in DMEM supplemented with 10% FBS and 1 mg/mL 324 hygromycin B. To reactivate iSLK cells, they were treated with 1 µg/mL doxycycline and 1 mM 325 sodium butyrate for 48 hours. 326 DNA transfections were carried out in 293T cells at 70-90% confluency in 10 cm plates 327 with 10 µg host-shutoff factor plasmid or vector control using PolyJet (SignaGen) 24 hours 328 before harvesting and again at 18 hours before harvesting. 329
Lentiviral transduction was carried out by spinfecting 1x10 6 293T or MC57G cells with 330 lentivirus made from 2 nd generation plasmids at a MOI <1 for 2 hours with 4 µg/mL polybrene 331 (Fisher). Twenty-four hours later puromycin (1 µg/ml for 293T or 3 µg/ml for MC57G) was 332 added to select for transduced cells. 293T cells stably expressing the kLANA-puromycin cassette 333 were made by transfecting the cells with 1 µg pGL3-kLANA-puromycin using PolyJet, then 334 selecting with puromycin for random integration events. 335
For the CMV-luciferase promoter assay, populations of 293T cells expressing muSOX 336 were selected 24 hours post-transfection using the Miltenyi Biotec MACS cell separation system 337 according to the manufacturer's instructions as previously described (22). 338
293T cells were infected with KSHV by reactivating iSLK-Bac16 cells for 48 hours and 339 then spinfecting cell-free virus onto a monolayer of 293T cells, as described for lentiviral 340 production but in the absence of polybrene. buffer. Samples were eluted twice with 100 µL 5% Beta-mercaptoethanol (BME) in DEPC H20 358 for 5 min then RNA was precipitated with isopropanol and quantified by RT-qPCR. 359
Viral mutagenesis, propagation and infections 360
The WT and R443I MHV68 bacterial artificial chromosome (BAC) were previously 361 described (6,50). MHV68 was produced by first making p0 virus by transfecting NIH 3T3 cells 362 in 6-well plates with 2.5 µg BAC DNA using TransIT-X2 (Mirus Bio) for 24h. Five to seven 363 days later, the cells were split into a 10 cm dish, then harvested and frozen. After 5-7 days the 364 majority of cells showed cytopathic effect (CPE). 30 µL of p0 was then added per confluent 10 365 cm dish of NIH 3T12 cells, split 2 days later into four 10 cm dishes and harvested 4-6 days later 366 when all cells were infected. Cells were collected by centrifugation (5 min, 1500 rpm) and the 367 pellet was dounced 10 times. The cell pellet and supernatant were then ultracentrifuged for 2 h at 368 30,000 rpm. The resulting pellet was resuspended and titered by plaque assay. Cells were 369 infected with MHV68 at an MOI of 5 for 24 hours. for -1000 to +1000 around the TTS with the same color scheme as (C). 481 
